Guarded N.I.H. Nominee Faces Sharp Questions on Vaccines and Research Cuts
Dr. Jay Bhattacharya, a professor of medicine at Stanford University, gained prominence during the Covid pandemic when he ...
HealthDay on MSN5d
Longtime NIH Leader Francis Collins Retires
Dr. Francis Collins, the famed geneticist who led the National Institutes of Health (NIH) for 12 years and helped guid ...
Science Daily1d
Research identifies key antibodies for development of broadly protective norovirus vaccine
Scientists have discovered a strategy to fight back against norovirus, a leading cause of gastroenteritis worldwide. Their new study identifies powerful antibodies capable of neutralizing a wide range ...
Scientific American3d
On COVID’s Fifth Anniversary, Scientists Reflect on Mistakes and Successes
Public health experts discuss lessons learned from the U.S. response to the COVID pandemic, on topics ranging from school ...
Cancer Therapy Advisor3d
Francis Collins Leaves NIH
Dr Francis Collins, the famed geneticist who led the National Institutes of Health for 12 years, has stepped down.
The Daily Signal2d
Restoring Trust in Public Health: Instead of Clinging to Arbitrary Mask Mandates, Ground Policy in Evidence-Based Data
Federal public health responses to COVID-19 revealed a myriad of shortcomings. Especially with regard to face mask protocols ...
Recalling the twisted tyranny of ‘follow the science’
Public health experts were never supposed to make policy but to advise those who do. During the pandemic, elected leaders didn't lead.
Trump’s FDA pick made his name by bashing the medical establishment. Soon he may be leading it
Food and Drug Administration nominee Dr. Marty Makary is known for his contrarian views and fiery criticism of traditional ...
The List on MSN7h
The Best Kate McKinnon Saturday Night Live Transformations
Kate McKinnon has played many hilarious characters on "SNL," but her most memorable transformations were when she ...
Measles confirmed in New York City infant and child. Here's how the virus can affect children.
CBS News New York has learned both New York measles patients -- an infant and a child from New York City -- have since ...
Omalizumab treats multi-food allergy better than oral immunotherapy, study finds
A clinical trial has found that the medication omalizumab, marketed as Xolair, treated multi-food allergy more effectively ...